It was aimed to bring together scientists, researchers, and clinicians from around the world to discuss recent developments in the field of cancer epigenetics. The symposium covered a range of topics, including epigenetic modifications in cancer cells, epigenetic therapy, and the potential use of epigenetic biomarkers in cancer diagnosis and prognosis.